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826 The Journal of Thoracic and CardioObjective: This study was undertaken to review the role of electrophysiology testing
and to determine the early and late results of medical and surgical management of
supraventricular tachyarrhythmias in Ebstein anomaly.
Methods: We reviewed 130 patients between 1990 and 2001 with Ebstein anomaly and
history of tachyarrhythmia with a median age of 25 years (mean age 27.5 years); 106
underwent electrophysiologic testing and 24 had documented atrial flutter or fibrillation.
We excluded 21 patients: negative results of testing (n 18), ventricular tachycardia (n
 2), and junctional tachycardia (n 1). The remaining 109 patients had more than one
mechanism: accessory pathway–mediated tachycardia (n  49), atrioventricular nodal
reentrant tachycardia (n  10), and atrial flutter/fibrillation (n  70).
Results: Eighty-three patients underwent at least one arrhythmia procedure combined
with surgery for Ebstein anomaly. Early mortality was 4.8%. Forty-one patients under-
went surgical ablation of an accessory pathway without recurrent accessory pathway–
mediated tachycardia at a mean follow-up of 48 months. Seven patients underwent
surgical perinodal cryoablation for atrioventricular nodal reentrant tachycardia without
recurrence at a mean follow-up of 57 months. Forty-eight patients underwent surgical
intervention for atrial flutter or fibrillation (right-sided maze procedure, n  38, and
cryoablation of the atrial isthmus, n  10). Freedom from recurrent atrial flutter or
fibrillation was 75% at a mean follow-up of 34 months.
Conclusion: Concomitant arrhythmia procedures can be performed without increase
in early mortality and should be added to Ebstein repairs for all patients who have
supraventricular tachyarrhythmias. Surgical procedures for accessory pathway–
mediated tachycardia and atrioventricular nodal reentrant tachycardia give excellent
(100%) freedom from recurrence of those arrhythmias. Surgical intervention for
atrial flutter/fibrillation yields freedom from late recurrence in 75% of cases.
Ebstein anomaly (EA) was first described in 1866 by Wilhelm Ebsteinafter examination of the heart of a cyanotic 19-year-old laborer whodied of tricuspid regurgitation related to a severe malformation of thetricuspid valve.1-3 EA is characterized by spiral displacement of theposterior and septal leaflets downward toward the apex of the rightventricle and is often associated with an atrial septal defect or other
cardiac anomaly.4 It is an uncommon congenital cardiac malformation accounting
for fewer than 1% of congenital heart defects. The pathologic abnormalities in EA,
including a markedly enlarged right atrium and right ventricle as well as associated
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Datrioventricular (AV) accessory conduction pathways
(APs), provide the substrate for the development of both
supraventricular and ventricular tachyarrhythmias. AP-
mediated reciprocating tachycardia (APMT), AV nodal
reentrant tachycardia (AVNRT), and atrial flutter or fi-
brillation (AFl/F) are the most common supraventricular
tachyarrhythmias found in this anomaly. Preexcitation
and Wolff-Parkinson-White syndrome are more fre-
quently associated with this anomaly (10%-29%) than
any other congenital heart defect.5,6 At least 15% of
patients with EA experience episodes of paroxysmal su-
praventricular tachycardia.6,7 Although current opera-
tions for EA, which include tricuspid valve repair or
replacement with correction of associated defects, are
highly successful and yield excellent early and late re-
sults,8-10 long-term outcome is still importantly affected
by the patient’s cardiac rhythm. The objectives of this
study were to review the role of electrophysiologic test-
ing in patients with EA associated with supraventricular
tachyarrhythmias and to determine the early and late
results of medical and surgical interventions for those
arrhythmias.
Methods
Study Population
From March 1, 1990, through October, 2001, we evaluated 130
patients (79 female) with EA and a history of tachyarrhythmias at
Mayo Clinic, Rochester, Minnesota. Diagnosis of EA was con-
firmed by echocardiography, which showed displacement and teth-
ering of the septal and posterior leaflets of the tricuspid valve.11-13
Patient age ranged from 9 months to 70 years (mean 27.5  18.0
years, median 25 years).
Patients were evaluated by review of available electrocardio-
grams (ECGs), and selected patients were referred for invasive
electrophysiologic testing. All patients with ECG evidence of
preexcitation underwent electrophysiologic testing to identify the
location and characteristics of their pathways. A total of 106
patients underwent electrophysiologic testing; 24 who had docu-
mented AFl/F according to baseline ECG or history were not
studied.
Twenty-one patients were excluded from subsequent review:
18 with negative results of electrophysiologic testing, 2 with
inducible ventricular tachycardia only, and 1 with inducible junc-
tional tachycardia only. The records of the remaining 109 patients
were reviewed retrospectively. These patients had mechanisms of
supraventricular tachyarrhythmias as follows: 49 with APMT, 10
with AVNRT, and 70 with AFl/F. Eighteen patients had multiple
mechanisms of supraventricular tachyarrhythmia (Figure 1).
Demographic and other patient-related data were obtained from
medical records. Recent follow-up information was obtained from
patient questionnaires, subsequent clinic visits, and written corre-
spondence with local physicians. Telephone interviews were ob-
tained from patients or families who did not respond to the ques-
tionnaires. This study was approved by the Mayo Foundation
institutional review board, and patients or parents gave informed
written consent.
The Journal of ThoraciStatistical Analysis
Continuous variables were expressed as range, mean  SD, and
median. Survival free from recurrent AFl/F was estimated accord-
ing to the Kaplan-Meier method. The log-rank test was used for
univariate analysis of type of surgical procedure for AFl/F (right-
sided maze procedure or cryoablation) on the rate of recurrence.
Early mortality was defined as death occurring within 30 days of
operation or at any time during the index hospitalization.
Surgical Technique
Some weak APs cease to function when the heart is cooled, when
cardiopulmonary bypass is instituted, or after administration of
cardioplegia. Accordingly, for patients with APMT, intraoperative
electrophysiologic mapping was begun at normothermia (37°C)
before institution of cardiopulmonary bypass. A multielectrode
sock was placed over the ventricles during sinus rhythm or atrial
pacing, and a multielectrode band was placed on the atrial side of
the AV groove during ventricular pacing or APMT. Points of
earliest activation were displayed on a computer template (Bard
Electrophysiology; C. R. Bard, Inc, Murray Hill, NJ). When nec-
essary, endocardial mapping on the atrial side of the tricuspid
valve annulus, ventricular septum, or both, was accomplished with
cardiopulmonary bypass that was established at normothermia. To
avoid loss of function of weak APs, administration of cold blood
cardioplegic solution was avoided until intracardiac mapping was
completed. The ascending aorta was temporarily crossclamped as
the right atrium was opened, and all atrial and ventricular septal
defects were rapidly closed. Any air on the left side was then
aspirated, the crossclamp was removed, and the heart was allowed
to be perfused and beating. The AV junction was mapped with a
rigid probe, and points of earliest atrial activation were noted
during ventricular pacing or APMT. Surgical ablation of the APs
was performed during cardioplegic arrest. Transmural incisions
were made in the right atrium 2 mm from the tricuspid annulus and
carried 1 cm down over the right ventricle.14 The dissected areas
Figure 1. Distribution of 129 arrhythmias in 109 patients.were lightly electrocoagulated and repaired by suture. For APs
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Dnear the conduction system, cryoablation was often used with the
heart beating to avoid permanent heart block. Repair or replace-
ment of the tricuspid valve was then carried out, together with
repair of all associated anomalies. When a valve repair was per-
formed, the heart was kept arrested and the field was kept blood-
less to optimize exposure of the anatomy. For tricuspid valve
replacement, the crossclamp was removed after suture placement
had been completed in the region cephalad to the conduction
tissue, and the heart was then allowed to be perfused and beating.15
After discontinuation of cardiopulmonary bypass, repeat electro-
physiologic testing was performed to test for residual AP function
or inducible APMT. Temporary atrial and ventricular pacing wires
were placed before sternal closure. When feasible, patients under-
going surgical ablation of APs had electrophysiologic testing per-
formed through their temporary atrial and ventricular pacing wires
before discharge from the hospital.
For patients with AVNRT, perinodal cryoablation was per-
formed after institution of cardiopulmonary bypass, right atri-
otomy, and closure of intracardiac septal defects (Frigitronics of
Connecticut, Shelton, Conn). Multiple applications of the cryo-
probe (freezes) were made at 70°C for 60 seconds around and
within the coronary sinus and then carried anteriorly toward the
proximal AV node until temporary complete heart block was
noted, at which time rewarming was begun immediately. In all
cases, normal AV conduction returned shortly thereafter. When
indicated, supplemental freezes were made superior and anterior to
the AV node and bundle of His.
For patients with AFl/F, two techniques were used. For most
patients without previous cardiac surgery, a right-sided maze pro-
cedure was performed as previously described elsewhere.16 If
there were dense adhesions as a result of previous cardiac surgery,
a cryoablation procedure, which included the right atrial isthmus,
was performed instead to minimize dissection, expedite the pro-
cedure, and lessen postoperative bleeding. Multiple cryoprobe
Figure 2. Location of cryoablation blocking lines for AFl/F. See
text for details. TV, Tricuspid valve; AVN, AV node; CS, coronary
sinus; SAN, sinoatrial node; SVC, superior vena cava; FO, foramen
ovale; IVC, inferior vena cava.freezes were placed to produce blocking lines across the right atrial
828 The Journal of Thoracic and Cardiovascular Surgery ● Deceisthmus from the posterolateral tricuspid annulus to the coronary
sinus to the inferior vena cava and the inferior atriotomy. Addi-
tional blocking lines were placed from the anterolateral tricuspid
annulus to the superior atriotomy and from the fossa ovalis to the
superior vena cava and superior atriotomy (Figure 2). Each freeze
was made at 70°C for 60 to 90 seconds, depending on the
thickness of tissue beneath the freezing probe.
Repair or replacement of the tricuspid valve was then performed,
and associated cardiac anomalies were repaired. At the conclusion of
the operation, redundant right atrium was resected (right reduction
atrioplasty) to reduce the right atrium to normal size.
Results
Of 109 patients, 84 (77%) underwent tricuspid valve re-
placement, 18 (17%) underwent tricuspid valve repair, and
7 (6%) had no operation. Overall, early operative mortality
was 7 (6.9%) of 102 patients. Eighty-three patients had
combined arrhythmia and EA corrective surgery; early mor-
tality in this subset was 4(4.8%) of 83 patients . This was
not significantly different from the early mortality for pa-
tients who underwent EA corrective surgery only (3/19
patients, 15.8%, P  .13).
In the APMT group (Table 1), 13 patients had undergone
one to three previous unsuccessful attempts at radiofre-
quency ablation elsewhere (n  11) or at our institution
(n  2). One of these had a stroke and another had a deep
vein thrombosis at the time of attempted ablation. Forty
patients had a single AP, one of which was weakly con-
ducting with a location that could not be identified. Nine
patients had two APs. Right posterolateral free wall was the
most common location, followed by posteroseptal and right
posterior free wall locations (Figure 3). Although uncom-
mon, Mahaim fiber–mediated tachycardia (n  2) and per-
manent form of junctional reciprocating tachycardia (n 1)
were found in some of our patients. None of the APs was
located on the left side of the heart.
All 49 patients underwent electrophysiologic testing: 9
preoperative testing only, 10 intraoperative testing only, and
30 both preoperative and intraoperative testing. In 1 of the
30 patients, the AP could not be mapped intraoperatively;
surgical ablation was therefore performed according to the
preoperative mapping results. Fifteen of the remaining 29
patients (52%) had concordance between the preoperative
and intraoperative mapping with regard to number and
location of APs.
In the AVNRT group (Table 1), 3 patients had both
APMT and AVNRT; 1 of them had manifest preexcitation.
In the AFl/F group (Table 1), 23 patients (33%) had under-
gone previous cardiac operations. Management of each ar-
rhythmia mechanism is summarized in Figure 4.
Management of APMT (n  49)
No intervention for AP (n  4). Four patients had nointervention for AP because the pathway had a long effec-
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Dtive refractory period and there was no inducible recipro-
cating tachycardia. Three of these did not require EA cor-
rective surgery because of mild tricuspid regurgitation. A
fourth patient underwent tricuspid valve replacement and
atrial septal defect closure; death occurred on the first op-
erative day from intractable right ventricular failure. The 3
survivors have had follow-ups of 100, 134, and 142 months;
none had recurrence of APMT.
Radiofrequency ablation for AP (n  6). Six patients
underwent attempted radiofrequency ablation procedures at
our institution, 4 of which were successful without death or
complication. In these 4 patients, the AP was located in the
right posterolateral free wall (n 3) or posteroseptal region
(n 1). Two patients with successful ablation subsequently
underwent EA corrective surgery with tricuspid valve re-
placement. All 4 patients were in sinus rhythm without
preexcitation at the time of hospital discharge. The 2 pa-
tients with unsuccessful catheter ablation were found to
have their APs located in the right posterolateral free wall
when the pathways were subsequently mapped and divided
at the time of EA corrective surgery. Two of the 4 patients
who underwent successful catheter ablation have been fol-
lowed up for 18 and 45 months without recurrence of
APMT. The remaining 2 patients were unavailable for
follow-up.
Surgical ablation of AP (n  41). All 41 patients
(100%) had successful surgical intervention for AP at the
time of EA corrective surgery: surgical division (n  26),
cryoablation (n  4), and combined surgical division and
cryoablation (n  11). Postprocedure intraoperative elec-
trophysiologic testing demonstrated no evidence of either
AP function or inducible APMT. There was one early death
from intractable right ventricular failure despite hemody-
namic support with an intra-aortic balloon pump and a right
ventricular assist device. He had no postoperative
arrhythmia.
One patient who had undergone 3 previous attempts at
catheter radiofrequency ablation elsewhere had complete
heart block develop on the second postoperative day. A
permanent pacemaker was placed; on follow-up, her rhythm
was predominantly normal AV conduction. Other nonfatal
complications included hypotension requiring intra-aortic
balloon pump placement (n  1), cardiac tamponade (n 
1), and pericardial effusion (n  1). Postoperative arrhyth-
mias included junctional rhythm (n  3), transient junc-
tional ectopic tachycardia (n  1), and nonsustained ven-
tricular tachycardia (n  1).
Discharge ECGs demonstrated sinus rhythm without pre-
excitation (n  37), junctional rhythm (n  2), and elec-
tronic dual-chamber pacing (n  1). Discharge electro-
physiologic testing was performed in 28 patients; all had no
evidence of AP function or inducible arrhythmia.
The Journal of ThoraciThirty-seven patients of the 40 early survivors (93%)
were followed up for 2 to 136 months (mean 48.1  38.0,
median 34). There were no late deaths. There were no
known recurrences of APMT. One patient had 3 episodes of
tachycardia of uncertain mechanism, not requiring any
treatment, during a 6-year period. Her initial ECG before
surgery demonstrated preexcitation; this was absent after
the operation, but her ECG after a 6-year follow-up sug-
gested return of preexcitation. Six patients had new onset of
AFl/F.
Management of AVNRT (n  10)
No intervention for AVNRT (n 3). Three patients did
not have EA corrective surgery or intervention for AVNRT
because of mild tricuspid regurgitation and minimal symp-
toms. One of them, an infant, died of diarrhea and dehy-
dration not associated with an arrhythmia 1 month after
electrophysiologic testing. Another patient who was fol-
lowed up for 122 months had new onset of atrial flutter but
not AVNRT. The third patient was unavailable for
follow-up.
Surgical intervention for AVNRT (n  7). Seven pa-
TABLE 1. Patient data and surgical procedures stratified
according to mechanism of arrhythmia
APMT
(n  49)
AVNRT
(n  10)
AF1/F
(n  70)
Female/male ratio 30:19 7:3 40:30
Age (y)
Mean  SD 18.4 13.1 19.7 14.5 33.4 18.1
Median 16 18 35
Range 0.75–50 1–44 1–68
Baseline ECG (%)
Sinus rhythm 100 100 86
With preexcitation 78 10 0
AF1/F 0 0 14
Arrhythmia symptoms (%)
Palpitation 65 90 84
Syncope 25 10 25
Presyncope 12 10 7
Dizziness 12 0 29
Transient ischemic attack 4 10 3
Out-of-hospital arrest 0 10 0
None 14 0 0
EA corrective surgery (%)
Tricuspid valve
replacement
69 70 77
Tricuspid valve repair 20 0 23
Atrial septal defect
closure
71 60 49
Patent foramen ovale
closure
10 10 12
Right reduction atrioplasty 71 50 71
Right ventricular plication 16 10 22
None 10 30 0
Previous cardiac surgery (%) 6 10 33tients underwent intraoperative perinodal cryoablation for
c and Cardiovascular Surgery ● Volume 128, Number 6 829
ia.
Surgery for Congenital Heart Disease Khositseth et al
CH
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had complete heart block develop. There was 1 early death
from intractable right ventricular failure; autopsy demon-
strated extensive fibrosis of the anterior wall of the right
ventricle. One patient had transient junctional ectopic tachy-
cardia; the discharge ECG showed junctional rhythm. In the
other 5 patients, normal conduction was seen on the dis-
charge ECG.
All 6 early survivors have been followed up for 9 to 72
Figure 3. Location of APs according to preoperativ
Permanent form of junctional reciprocating tachycard
Figure 4. Management of supraventricular tachyarrhyt
more than one arrhythmia procedure at operation. Sg,
patients in group subsequently underwent surgery f
cryoablation.months (mean 57.3  24.3, median 66). The last ECG of
830 The Journal of Thoracic and Cardiovascular Surgery ● Deceeach showed sinus rhythm, and there has not been any
recurrence of AVNRT. One patient had new-onset atrial
flutter.
Management of AFl/F (n  70)
No intervention for AFl/F(n  22). Twenty-two pa-
tients underwent EA corrective surgery for tricuspid regur-
gitation and associated defects without any intervention for
the AFl/F; most of these patients were treated in the early
d/or intraoperative electrophysiology testing. PJRT,
s according to their mechanisms. Some patients had
ry; RFA, radiofrequency ablation. Asterisk indicates 2
P; dagger indicates combined surgical division ande anhmia
Surge
or Apart of this series, before effective surgical arrhythmia pro-
mber 2004
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Dcedures became available. There were 3 early deaths. Two
patients died of ventricular arrhythmias; 1, a 44-year-old
woman, underwent an autopsy that showed severe coronary
artery disease and acute myocardial infarction. The third
patient was the same one described in the AVNRT group
who had right ventricular fibrosis.
Sixteen of the 19 early survivors (84%) were followed up
from 3 to 140 months (mean 57.2  47.7 months, median
46 months). There were 2 late deaths, 3 and 23 months after
operation, both of sudden cardiac arrest. Eight of the known
14 late survivors had no recurrence of arrhythmias. The
remaining 6 patients had recurrent AFl/F requiring antiar-
rhythmic drugs; 2 of the 6 subsequently underwent success-
ful radiofrequency ablation of atrial flutter.
Right-sided maze procedure (n  38). Thirty-eight pa-
tients underwent a concomitant right-sided maze procedure
at the time of EA corrective surgery. There were 2 early
deaths, both of myocardial infarction. No patients had com-
plete heart block develop. Postoperative arrhythmias in-
cluded transient junctional rhythm (n  3), transient AFl/F
(n  2), transient ventricular arrhythmia (n  1), and
persistent atrial fibrillation (n  1). The discharge ECG
demonstrated sinus rhythm (n  31), ectopic atrial rhythm
(abnormal P axis, n  2), junctional rhythm (n  2), and
atrial fibrillation (n  1).
Thirty-five of the 36 early survivors (97%) were fol-
lowed up from 6 to 87 months (mean 39.0  25.4 months,
median 38 months). There were no late deaths. Twenty-five
patients (71%) had no recurrence of arrhythmia. Ten pa-
tients (29%) had recurrent AFl/F; 2 of them had chronic
atrial fibrillation before the operation that persisted after-
ward. The remaining 8 patients had paroxysmal AFl/F be-
fore the operation that recurred from 1 to 15 months after-
ward. Two of the 8 patients underwent radiofrequency
ablation for atrial flutter, but 1 patient had recurrent atrial
flutter 13 months after ablation and a second attempted
ablation was not successful. Two of the remaining 6 patients
had only a single episode of recurrent AFl/F at 3 and 12
months after operation, and they did not require any anti-
arrhythmic drugs. Four of the 6 patients required antiar-
rhythmic drugs because of more than one recurrent episode.
At last follow-up ECG, only 2 of the 35 known late survi-
vors (6%) were still in AFl/F.
Cryoablation procedure (n  10). Ten patients under-
went a cryoablation procedure for treatment of AFl/F at the
time of EA corrective surgery. There were no early deaths.
Postoperative arrhythmias included transient accelerated
junctional rhythm reverting to atrial fibrillation (n  1),
atrial flutter requiring amiodarone (n  1), and high-grade
(Mobitz II) AV block requiring insertion of a DDD pace-
maker (n  1). The discharge ECG demonstrated sinus
rhythm (n 8), atrial fibrillation (n 1), and dual-chamber
pacemaker rhythm (n  1).
The Journal of ThoraciNine of the 10 early survivors were followed up from 6
to 60 months (mean 19.7  17.9 months, median 14
months). There were no late deaths. Eight patients had no
recurrence of AFl/F. One patient had chronic atrial fibrilla-
tion and was receiving amiodarone. One patient had new
onset of ventricular tachycardia, which was successfully
controlled by radiofrequency ablation.
The freedom from recurrent AFl/F in the 48 patients who
underwent either a right-sided maze or cryoablation proce-
dures was 74.6%  7.1% at mean follow-up of 34 months
(Figure 5,A). The rate of recurrence was not significantly
different between the two procedures (p 0.5; Figure 5, B).
Overall, in the combined surgical intervention group, only 3
of the 44 late survivors followed up (7%) still had chronic
Figure 5. A, Freedom from recurrent AFl/F in all patients who
underwent surgical management (right-sided maze procedure or
cryoablation). B, Freedom from recurrent AFl/F in patients who
underwent right-sided maze procedure (line A) or cryoablation of
the atrial isthmus (line B, P  .5).AFl/F.
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Patients with EA may have a wide spectrum of symptoms,
depending in large part on hemodynamic variables includ-
ing severity of tricuspid regurgitation, degree of right-to-left
shunting across a patent foramen ovale or atrial septal
defect, and severity of right ventricular dysfunction. Symp-
toms are also influenced by presence of associated congen-
ital cardiac anomalies, especially stenosis of the right ven-
tricular outflow tract or pulmonary valve. Moreover,
supraventricular tachyarrhythmias are commonly associated
with this anomaly, causing palpitations, presyncope, syn-
cope, or even sudden cardiac death. Such tachyarrhythmias
are poorly tolerated because of the hemodynamic and ana-
tomic abnormalities associated with EA. Current surgical
procedures of tricuspid valve repair or replacement com-
bined with correction of associated cardiac defects are
highly successful and yield excellent early and late re-
sults.8-10 Management of supraventricular tachyarrhythmias
associated with EA can be challenging. Nevertheless, it is
clear that effective control of these arrhythmias is important
for optimal patient outcome.
We agree with others17who favor preoperative electro-
physiologic testing for all patients with EA who have evi-
dence of preexcitation on ECG or who have a history of
wide-complex tachycardia or tachyarrhythmia of unknown
type. Electrophysiologic testing can help to identify the
presence, number, and characteristics of APs. In this review,
concealed pathways were found in 11 additional patients
with history of tachyarrhythmia who did not have evidence
of preexcitation on ECG. Electrophysiologic testing can
also identify possible associated mechanisms for supraven-
tricular tachyarrhythmias such as AVNRT and easily induc-
ible AFl/F. In this review, 18 patients had more than one
mechanism for arrhythmia. Because surgical procedures are
now available to treat these arrhythmias, their proper iden-
tification before EA corrective surgery is important for
optimal rhythm control after operation.
Most APs in patients with EA with situs solitus and AV
concordance are located on the right side (98.5% in one
registry’s experience18 and 100% in this review). Preoper-
ative electrophysiologic mapping and radiofrequency abla-
tion of APs are complicated in patients with EA for several
reasons. Apical displacement of the tricuspid valve away from
the annulus creates tricuspid regurgitation and a broad area of
atrialized right ventricle, which may prevent adequate catheter
stability. The right atrium and right ventricle are characteristi-
cally enlarged, sometimes massively, distorting the anatomic
landmarks and making the AV junction difficult to locate and
target with catheters. Multiple APs are common18,19 (present in
9 of 49 patients in this review), and our intraoperative mapping
studies and the preoperative mapping reports of others19,20
have shown that some APs are actually broad bands rather than
the discrete, microscopic pathways typically found in patients
832 The Journal of Thoracic and Cardiovascular Surgery ● Decewithout EA. In addition, a tendency toward development of
atrial fibrillation during catheter manipulation can complicate
mapping and ablation. These limitations principally account
for the finding that there was complete concordance between
the results of our preoperative and intraoperative mapping
procedures regarding number and location of APs only 52% of
the time.
Campbell and colleagues21 reported the results of a pe-
diatric registry in which there was an acute success rate of
92% for catheter ablation of all known APs (4462/4838
pathways); however, the acute success rate for left free wall
APs was higher than for right free wall APs (96.5% vs
88.6%). Unlike these highly successful rates of catheter
ablation of APs in the general population (95%), the acute
success rate of catheter ablation of APs in patients with EA
is lower (81%).18,19 Only 4 of 6 patients at our institution
had successful ablation, and 11 of the patients in this review
had previously undergone one to three unsuccessful at-
tempts at catheter ablation elsewhere. Similar results have
been reported from other institutions. In one report from a
large pediatric radiofrequency ablation registry, the acute
success rate (defined as absence of the arrhythmia on leav-
ing the electrophysiologic laboratory) for catheter ablation
of APs in 56 patients with EA was 81%, and the 1-year
success rate was only 57%.18 In a smaller series, 16 of 21
patients with EA (76%) had early ablation success after 1 to
3 sessions, but 4 of the 16 had arrhythmia recurrence during
a mean follow-up of 22 months, for a late success rate of
57%.19 Because the late success rate for catheter ablation of
APs in EA is suboptimal,18,19 we favor primary reliance on
surgical ablation, which has been highly effective in our
experience and that of others.22-24 An ablation attempt may
be made during preoperative electrophysiologic testing, but
if success is not readily achieved, the APs can be remapped
and ablated at the time of EA corrective surgery. In this
review, there was no increase in early mortality when con-
comitant surgical ablation of APs was performed during EA
corrective surgery (1 of 41 patients, 2.4%).
Cox and colleagues25 reported successful cryosurgery of
the perinodal tissues for AVNRT in 23 patients. Although
we had a small number of patients with AVNRT, perinodal
cryoablation for AVNRT was successful in all 10 patients
with no complications and no recurrence of arrhythmia
related to AVNRT at follow-up.
The most common supraventricular tachyarrhythmias
seen in patients with EA are atrial flutter and atrial fibrilla-
tion (70/129, 54% in this review). AFl/F is more frequent in
older patients; the median age was 35 years compared with
16 years for APMT and 18 years for AVNRT. AFl/F is also
more common after previous cardiac surgery; new-onset
AFl/F developed during follow-up in 6 patients after oper-
ation for APMT and in 1 patient after operation for
AVNRT. The large size of the right atrium in EA and the
mber 2004
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substrates for these arrhythmias. At operation, they are
addressed by right reduction atrioplasty and by placing
surgical incisions or cryoablation blocking lines to prevent
atrial reentry circuits. Before the availability of surgical
arrhythmia procedures, some patients in this review had no
further AFl/F after EA corrective surgery in which the
tricuspid valve was made competent and a right reduction
atrioplasty was performed (8 of 14 survivors, 57%). How-
ever, freedom from arrhythmia recurrence was improved
with the addition of a right-sided maze or cryoablation
procedure (33/44, 75%, P  .06). It is encouraging that
even when there was a recurrence, chronic atrial fibrillation
could be reduced to 7% by the adjunctive use of antiarrhyth-
mic drugs, catheter ablation, or both.
The addition of one or more concomitant arrhythmia
procedures at the time of EA corrective surgery did not
increase the early mortality in this study (4.8%) relative to
the overall mortality rate of 6.8% for our overall series of
498 patients undergoing operation for EA (unpublished
observations).
Conclusions
Electrophysiologic testing plays an important role in the
diagnosis and management of patients with EA and su-
praventricular tachyarrhythmias. Therefore all patients with
documented tachycardia or a history of palpitations should
undergo preoperative electrophysiologic testing regardless
of evidence of preexcitation. Because the late success rate
for catheter ablation of APs in EA is suboptimal, we favor
primary reliance on surgical ablation. Concomitant arrhyth-
mia procedures can be combined with EA corrective sur-
gery without increase in early mortality; we conclude they
should be added to EA repairs for all patients who have
supraventricular tachyarrhythmias. Surgical intervention for
APMT and AVNRT yielded excellent freedom from recur-
rence of these arrhythmias. Surgical intervention for AFl/F
yielded freedom from late recurrence in 75% of patients, but
after adjunctive medical or catheter therapy only 7% of late
survivors were still in AFl/F.
We gratefully acknowledge the statisticians at the Mayo Clinic
Center for Patient Oriented Research for statistical assistance.
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